MMP-14 degrades tropoelastin and elastin.


Journal

Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 07 05 2019
accepted: 01 07 2019
pubmed: 7 7 2019
medline: 26 2 2020
entrez: 7 7 2019
Statut: ppublish

Résumé

Matrix metalloproteinases are a class of enzymes, which degrade extracellular matrix components such as collagens, elastin, laminin or fibronectin. So far, four matrix metalloproteinases have been shown to degrade elastin and its precursor tropoelastin, namely matrix metalloproteinase-2, -7, -9 and -12. This study focuses on investigating the elastinolytic capability of membrane-type 1 matrix metalloproteinase, also known as matrix metalloproteinase-14. We digested recombinant human tropoelastin and human skin elastin with matrix metalloproteinase-14 and analyzed the peptide mixtures using complementary mass spectrometric techniques and bioinformatics tools. The results and additional molecular docking studies show that matrix metalloproteinase-14 cleaves tropoelastin as well as elastin. While tropoelastin was well degraded, fewer cleavages occurred in the highly cross-linked mature elastin. The study also provides insights into the cleavage preferences of the enzyme. Similar to cleavage preferences of matrix metalloproteinases-2, -7, -9 and -12, matrix metalloproteinase-14 prefers small and medium-sized hydrophobic residues including Gly, Ala, Leu and Val at cleavage site P1'. Pro, Gly and Ala were preferably found at P1-P4 and P2'-P4' in both tropoelastin and elastin. Cleavage of mature skin elastin by matrix metalloproteinase-14 released a variety of bioactive elastin peptides, which indicates that the enzyme may play a role in the development and progression of cardiovascular diseases that go along with elastin breakdown.

Identifiants

pubmed: 31278967
pii: S0300-9084(19)30192-0
doi: 10.1016/j.biochi.2019.07.001
pii:
doi:

Substances chimiques

Tropoelastin 0
Elastin 9007-58-3
MMP14 protein, human EC 3.4.24.80
Matrix Metalloproteinase 14 EC 3.4.24.80

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-39

Informations de copyright

Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Auteurs

Natalia Miekus (N)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany; Department of Pharmaceutical Chemistry, Medical University of Gdańsk, Gdańsk, Poland; Department of Animal and Human Physiology, Faculty of Biology, University of Gdańsk, Gdańsk, Poland.

Chiara Luise (C)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Wolfgang Sippl (W)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Tomasz Baczek (T)

Department of Pharmaceutical Chemistry, Medical University of Gdańsk, Gdańsk, Poland.

Christian E H Schmelzer (CEH)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany; Fraunhofer Institute for Microstructure of Materials and Systems IMWS, Halle (Saale), Germany.

Andrea Heinz (A)

Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany; Department of Pharmacy, LEO Foundation Center for Cutaneous Drug Delivery, University of Copenhagen, Copenhagen, Denmark. Electronic address: andrea.heinz@sund.ku.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH